Harold Bernstein, the President of $MAZE, sold 16,142 shares of the company on 08-13-2026 for an estimated $445,620. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $MAZE stock.
$MAZE Insider Trading Activity
$MAZE insiders have traded $MAZE stock on the open market 38 times in the past 6 months. Of those trades, 0 have been purchases and 38 have been sales.
Here’s a breakdown of recent trading of $MAZE stock by insiders over the last 6 months:
- HAROLD BERNSTEIN (President, R&D & CMO) has made 0 purchases and 12 sales selling 105,995 shares for an estimated $3,911,990.
- JASON V COLOMA (Chief Executive Officer) has made 0 purchases and 17 sales selling 138,005 shares for an estimated $3,753,546.
- ATUL DANDEKAR (CSBO) has made 0 purchases and 7 sales selling 37,500 shares for an estimated $1,023,052.
- AMY BACHRODT (SVP, Finance) has made 0 purchases and 2 sales selling 2,500 shares for an estimated $73,610.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MAZE Hedge Fund Activity
We have seen 105 institutional investors add shares of $MAZE stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARADIGM BIOCAPITAL ADVISORS LP removed 2,744,399 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $81,892,866
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,178,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $35,163,300
- JPMORGAN CHASE & CO added 964,011 shares (+inf%) to their portfolio in Q2 2026, for an estimated $28,766,088
- BLACKROCK, INC. added 932,416 shares (+36.3%) to their portfolio in Q2 2026, for an estimated $27,823,293
- BELLEVUE GROUP AG removed 887,708 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $26,498,083
- DEEP TRACK CAPITAL, LP removed 768,878 shares (-18.1%) from their portfolio in Q1 2026, for an estimated $22,951,008
- CORMORANT ASSET MANAGEMENT, LP added 750,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $22,387,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MAZE Analyst Ratings
Wall Street analysts have issued reports on $MAZE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 03/18/2026
To track analyst ratings and price targets for $MAZE, check out Quiver Quantitative's $MAZE forecast page.
$MAZE Price Targets
Multiple analysts have issued price targets for $MAZE recently. We have seen 7 analysts offer price targets for $MAZE in the last 6 months, with a median target of $58.0.
Here are some recent targets:
- Danielle Brill from Truist Securities set a target price of $64.0 on 04/14/2026
- Anupam Rama from JP Morgan set a target price of $58.0 on 03/31/2026
- Ananda Ghosh from HC Wainwright & Co. set a target price of $110.0 on 03/25/2026
- Julian Harrison from BTIG set a target price of $46.0 on 03/25/2026
- Laura Chico from Wedbush set a target price of $58.0 on 03/16/2026
- Salim Syed from Mizuho set a target price of $97.0 on 03/10/2026
- Debjit Chattopadhyay from Guggenheim set a target price of $58.0 on 03/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
